Patrycja Burzyńska
Research Subjects
Patrycja Burzyńska has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Lukasz Filip Sobala
Laboratory of Glycobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland
2 shared publications Ewa Jaśkiewicz
1 shared publication- Ewa Jaśkiewicz1 shared publication
- Jan Czujkowski
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla, 553-114 Wroclaw, Poland
1 shared publication - Krzysztof Mikołajczyk
Laboratory of Glycobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla St. 12, 53-114, Wroclaw, Poland
1 shared publication Marlena Jodłowska
Hirszfeld Institute of Immunology and Experimental Therapy, PAS
1 shared publication
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Basigin N-glycans may interfere with Plasmodium falciparum Rh5 merozoite ligand interaction
The molecular mechanisms underlying host invasion by Plasmodium malaria parasites still require better understanding. The blood stage of the infection is particularly interesting because it is a key step in parasite invasion. Erythrocyte basigin (BSG) is a crucial receptor for the recognition of host red blood cells (RBCs), and blocking it can protect against this merozoite stage of infection.This work aims to determine the role of BSG N‑glycans in the binding of the P. falciparum Rh5 ligand. We obtained recombinant human BSG, its glycosylation mutants, and the recombinant P. falciparum Rh5 protein. Four glycosylation mutants of BSG, lacking one of the three N‑glycoside chains linked to asparagine 44, 152, or 186, and a deglycosylated variant, allowed for the examination of BSG binding by the Rh5 ligand. All recombinant proteins were obtained in mammalian HEK293F cells and characterized for purity by SDS‑PAGE and Western blotting. The SPR technique was used to analyze BSG binding to the Rh5 protein. Our results show that the removal of any BSG N‑glycan increased Rh5 ligand binding to the recombinant BSG. It might suggest that all BSG glycans, and especially the N44 glycan, not only participate in Rh5 binding but also hinder it. We propose that BSG glycosylation might be a human evolutionary adaptation that prevents erythrocyte invasion by Plasmodium parasites.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessBasigin N-glycans may interfere with Plasmodium falciparum Rh5 merozoite ligand interaction
The molecular mechanisms underlying host invasion by Plasmodium malaria parasites still require better understanding. The blood stage of the infection is particularly interesting because it is a key step in parasite invasion. Erythrocyte basigin (BSG) is a crucial receptor for the recognition of host red blood cells (RBCs), and blocking it can protect against this merozoite stage of infection.This work aims to determine the role of BSG N‑glycans in the binding of the P. falciparum Rh5 ligand. We obtained recombinant human BSG, its glycosylation mutants, and the recombinant P. falciparum Rh5 protein. Four glycosylation mutants of BSG, lacking one of the three N‑glycoside chains linked to asparagine 44, 152, or 186, and a deglycosylated variant, allowed for the examination of BSG binding by the Rh5 ligand. All recombinant proteins were obtained in mammalian HEK293F cells and characterized for purity by SDS‑PAGE and Western blotting. The SPR technique was used to analyze BSG binding to the Rh5 protein. Our results show that the removal of any BSG N‑glycan increased Rh5 ligand binding to the recombinant BSG. It might suggest that all BSG glycans, and especially the N44 glycan, not only participate in Rh5 binding but also hinder it. We propose that BSG glycosylation might be a human evolutionary adaptation that prevents erythrocyte invasion by Plasmodium parasites.